Abstract: A method of analyzing a specific medical treatment provides efficient and effective statistical results to be included in a preponderance of evidence and/or affidavit of merit for any allegation of negligence. Following standards of care, the method creates a hypothetical treatment and determines an associated background risk of adverse outcome thereof. The method subdivides both the hypothetical treatment and the specific treatment into individual phases. By comparing the specific treatment with the hypothetical treatment in each phase, the method generates the relative risks for the phases of the specific treatment and groups them into a sample. Conducting a Student t-test with a predetermined level of confidence, the method tests a null hypothesis that the risk of an adverse outcome for the specific treatment is not significantly different from the hypothetical treatment, thus the specific treatment conforms to the standards of care. This method can help make medicine great again.

Abstract: A system, station and corresponding methods for providing warning notifications. In one exemplary method, it is determined whether any of a plurality of stations to which a Warning Notification is to transmitted is in a connected state. When it is determined that a first one of the stations is in a connected state, generating, by a broadcaster, a secondary Warning Notification formatted for transmission over a dedicated control channel (DCCH) and transmitting, by the broadcaster, the secondary Warning Notification to the first station over the DCCH. In another exemplary embodiment, a station for receiving emergency notifications is described. The station includes a receiver configured to receive a primary Warning Notification; and a processor which, upon receiving the emergency alert configuration in a format of one of a Paging Type 2 message and an SICI message, despreads a plurality of fingers.

Abstract: A method, station and computer readable storage medium used for location aware network selection. A station determines a geographic location of the station, determines at least one predetermined Public Land Mobile Network (PLMN) in the geographic location by comparing the geographic location to a database including stored geographic locations and PLMNs known to be present within each of the geographic locations, performs a targeted scan on select channels corresponding to the at least one predetermined PLMN to identify at least one available PLMN from among the at least one predetermined PLMN and selects one of the at least one available PLMN for the station to join.

Abstract: A system, station and corresponding methods for providing warning notifications. In one exemplary method, it is determined whether any of a plurality of stations to which a Warning Notification is to transmitted is in a connected state. When it is determined that a first one of the stations is in a connected state, generating, by a broadcaster, a secondary Warning Notification formatted for transmission over a dedicated control channel (DCCH) and transmitting, by the broadcaster, the secondary Warning Notification to the first station over the DCCH. In another exemplary embodiment, a station for receiving emergency notifications is described. The station includes a receiver configured to receive a primary Warning Notification; and a processor which, upon receiving the emergency alert configuration in a format of one of a Paging Type 2 message and an SICI message, despreads a plurality of fingers.

Abstract: A clock-data recovery doubler circuit for digitally encoded communications signals is provided. A window comparator includes two thresholds. A clock output is created by the window comparator and also used internally as feedback. Based on the clock output, the window comparator circuit collapses the thresholds while sampling input Bipolar return to zero data.

Abstract: A clock-data recovery doubler circuit for digitally encoded communications signals is provided. A window comparator includes two thresholds. A clock output is created by the window comparator and also used internally as feedback. Based on the clock output, the window comparator circuit collapses the thresholds while sampling input Bipolar return to zero data.

Abstract: The present invention relates to certain pharmaceutical compositions containing at least one vasopressin receptor antagonist and at least one angiotensin receptor blocker (ARB) and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of vasopressin and/or angiotensin-mediated disorders.

Abstract: The present invention provides a method for treating hematological disorders such as anemia and thrombocytopenia, whereby a TPO mimetic peptide compound is administered using a specified dosing regimen. The dosing regimen involves the administration of the TPO mimetic peptide compound within a specified time frame surrounding administration of a chemotherapeutic agent. The dosing regimen also involves monitoring subject response in order to determine future course of treatment.

Abstract: The present invention relates to certain pharmaceutical compositions containing at least one vasopressin receptor antagonist and at least one angiotensin converting enzyme (ACE) inhibitor and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of vasopressin and/or angiotensin converting enzyme mediated disorders.

Abstract: The present invention relates to the use of enoxaparin for treating a disease linked to the modulation of heparanase activity.

Abstract: The invention is directed to pharmaceutical composition comprising a compound having adenosine A1/A2 agonistic activity, a sodium-hydrogen exchanger inhibitory compound and a pharmaceutically acceptable carrier. The invention is also directed to a method cardioprotection in a patient in need thereof comprising administering to said patient pharmaceutically effective amounts of a compound having adenosine A1/A2 agonistic activity and a sodium-hydrogen exchanger inhibitory compound. This invention is also directed to the use of pharmaceutically effective amounts of a compound having adenosine A1/A2 agonistic activity and a sodium-hydrogen exchanger inhibitory compound in the preparation of a medicament for providing cardioprotection to a patient in need thereof.